BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38556106)

  • 1. PGR-KITLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells.
    Yang Z; Chen H; Yin S; Mo H; Chai F; Luo P; Li Y; Ma L; Yi Z; Sun Y; Chen Y; Wu J; Wang W; Yin T; Zhu J; Shi C; Zhang F
    Cancer Lett; 2024 May; 589():216795. PubMed ID: 38556106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mast cells arise from a common circulating progenitor.
    Maaninka K; Lappalainen J; Kovanen PT
    J Allergy Clin Immunol; 2013 Aug; 132(2):463-9.e3. PubMed ID: 23582567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling.
    Das Roy L; Curry JM; Sahraei M; Besmer DM; Kidiyoor A; Gruber HE; Mukherjee P
    Breast Cancer Res; 2013 Apr; 15(2):R32. PubMed ID: 23577751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
    Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
    Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype.
    Majorini MT; Cancila V; Rigoni A; Botti L; Dugo M; Triulzi T; De Cecco L; Fontanella E; Jachetti E; Tagliabue E; Chiodoni C; Tripodo C; Colombo MP; Lecis D
    Cancer Res; 2020 Jun; 80(11):2311-2324. PubMed ID: 32179512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-to-nucleus signaling links insulin-like growth factor-1- and stem cell factor-activated pathways.
    Hayashi Y; Asuzu DT; Gibbons SJ; Aarsvold KH; Bardsley MR; Lomberk GA; Mathison AJ; Kendrick ML; Shen KR; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Farrugia G; Urrutia RA; Ordog T
    PLoS One; 2013; 8(10):e76822. PubMed ID: 24116170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
    Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
    J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers.
    Chen EC; Karl TA; Kalisky T; Gupta SK; O'Brien CA; Longacre TA; van de Rijn M; Quake SR; Clarke MF; Rothenberg ME
    Gastroenterology; 2015 Sep; 149(3):705-17.e2. PubMed ID: 26026391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative mast cell analysis and hormone receptor study (ER, PR and HER2/neu) in invasive carcinoma of breast.
    Pyla RD; Potekar RM; Patil VS; Reddy AK; Sathyashree KV
    Indian J Pathol Microbiol; 2020; 63(2):200-204. PubMed ID: 32317515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.
    Johnson C; Huynh V; Hargrove L; Kennedy L; Graf-Eaton A; Owens J; Trzeciakowski JP; Hodges K; DeMorrow S; Han Y; Wong L; Alpini G; Francis H
    Am J Pathol; 2016 Jan; 186(1):123-33. PubMed ID: 26597881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An In Vitro Model of Mast Cell Recruitment and Activation by Breast Cancer Cells Supports Anti-Tumoral Responses.
    Aponte-López A; Enciso J; Muñoz-Cruz S; Fuentes-Pananá EM
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells.
    Yang S; Li WS; Dong F; Sun HM; Wu B; Tan J; Zou WJ; Zhou DS
    J Cell Mol Med; 2014 Oct; 18(10):2092-102. PubMed ID: 25213795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy.
    Chic N; Schettini F; Brasó-Maristany F; Sanfeliu E; Adamo B; Vidal M; Martínez D; Galván P; González-Farré B; Cortés J; Gavilá J; Saura C; Oliveira M; Pernas S; Martínez-Sáez O; Soberino J; Ciruelos E; Carey LA; Muñoz M; Perou CM; Pascual T; Bellet M; Prat A
    EBioMedicine; 2021 Jul; 69():103451. PubMed ID: 34161883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.
    Glajcar A; Szpor J; Pacek A; Tyrak KE; Chan F; Streb J; Hodorowicz-Zaniewska D; Okoń K
    Virchows Arch; 2017 May; 470(5):505-515. PubMed ID: 28315938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.
    Põlajeva J; Sjösten AM; Lager N; Kastemar M; Waern I; Alafuzoff I; Smits A; Westermark B; Pejler G; Uhrbom L; Tchougounova E
    PLoS One; 2011; 6(9):e25222. PubMed ID: 21949886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment.
    Xie Z; Niu L; Zheng G; Du K; Dai S; Li R; Dan H; Duan L; Wu H; Ren G; Dou X; Feng F; Zhang J; Zheng J
    Cell Biosci; 2023 Nov; 13(1):217. PubMed ID: 38031173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.
    Yang Z; Liu S; Wang Y; Chen Y; Zhang P; Liu Y; Zhang H; Zhang P; Tao Z; Xiong K
    Thorac Cancer; 2020 Jul; 11(7):1944-1954. PubMed ID: 32463597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy.
    Fereydouni M; Ahani E; Desai P; Motaghed M; Dellinger A; Metcalfe DD; Yin Y; Lee SH; Kafri T; Bhatt AP; Dellinger K; Kepley CL
    Front Oncol; 2022; 12():871390. PubMed ID: 35574362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib stimulates human skin type mast cell degranulation and maturation.
    Mizukami Y; Sugawara K; Kira Y; Tsuruta D
    J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional p53 responsive polymorphism in KITLG, rs4590952, does not affect the risk of breast cancer.
    Chen W; Li J; Liu C; Chen X; Zhu Y; Yang Y; Gong Y; Wang T; Miao X; Nie X
    Sci Rep; 2014 Sep; 4():6371. PubMed ID: 25220285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.